Anticoagulation in clinical practice -2nd Part: the use of heparins

Bibliographic Details
Main Author: Timóteo, Ana Teresa
Publication Date: 1998
Other Authors: Pais, Maria João
Format: Article
Language: por
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: https://revista.spmi.pt/index.php/rpmi/article/view/2163
Summary: The authors review, in this, the second part of the theme "anticoagulation in clinical prac­tice", the use of heparins in clinical practice. First, the use of unfractionated heparin, is discussed its indicated uses in inpatients, with often consequent long in-patient admission ti­mes, as well as the disadvantages of its use on the outpatient basis e.g. difficult use at home and complex monitorisation. Secondly, the authors' present low molecular weight hepa­rins, which combine easy administration with easy monitorisation, making their total cost lower than that of unfractionated heparin. Caution must be exercised in their implemen­tation, as each low molecular weight heparin has an individual profile that must be asses­sed in each clinical situation. To date, all studies point to a beneficial effect with the use of the various unfractionated heparins in their different clinical settings. lt seems probable that new indications will appear.
id RCAP_c930f912d61e2adbce4b56223824507f
oai_identifier_str oai:oai.revista.spmi.pt:article/2163
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Anticoagulation in clinical practice -2nd Part: the use of heparinsAnticoagulação na prática clínica -2ªparte: utilização das heparinasheparina não fraccionadaheparinas de baixo peso moleculartrombo­ citopéniaactividade anti-Xaunfractionated heparinlow-mo­lecular weight heparinthrombocytopeniaanti­ Xa activityThe authors review, in this, the second part of the theme "anticoagulation in clinical prac­tice", the use of heparins in clinical practice. First, the use of unfractionated heparin, is discussed its indicated uses in inpatients, with often consequent long in-patient admission ti­mes, as well as the disadvantages of its use on the outpatient basis e.g. difficult use at home and complex monitorisation. Secondly, the authors' present low molecular weight hepa­rins, which combine easy administration with easy monitorisation, making their total cost lower than that of unfractionated heparin. Caution must be exercised in their implemen­tation, as each low molecular weight heparin has an individual profile that must be asses­sed in each clinical situation. To date, all studies point to a beneficial effect with the use of the various unfractionated heparins in their different clinical settings. lt seems probable that new indications will appear.Os autores revêm, numa segunda parte do tema "Anticoagulação na prática clínica" a utilização das heparinas na prática clínica. Inicialmente, é abordada a heparina não frac­cionada que, apesar de ser extremamente útil e eficaz nas utilizações referidas no artigo, tem como grandes desvantagens a impossibi­lidade de administração no domicílio e uma monitorização difícil, implicando assim a sua utilização intra-hospitalar e internamentos mais prolongados. Em alternativa, são apre­sentadas as várias heparinas de baixo peso molecular, que aliam a facilidade de adminis­tração com a simplicidade de monitorização, tornando o seu custo total menor que o das heparinas não fraccionadas. No entanto, a sua implementação deve ser cautelosa, porque cada uma destas heparinas tem características próprias que devem ser avaliadas individu­almente para cada indicação. Os estudos re­alizados até hoje apontam para uma eficá­cia em todas as indicações da heparina não fraccionada e, provavelmente, irá surgir um vasto leque de novas indicações para estas novas moléculas.Sociedade Portuguesa de Medicina Interna1998-12-31info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://revista.spmi.pt/index.php/rpmi/article/view/2163Internal Medicine; Vol. 5 No. 4 (1998): Outubro/ Dezembro; 264-270Medicina Interna; Vol. 5 N.º 4 (1998): Outubro/ Dezembro; 264-2702183-99800872-671Xreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAPporhttps://revista.spmi.pt/index.php/rpmi/article/view/2163https://revista.spmi.pt/index.php/rpmi/article/view/2163/1531Timóteo, Ana TeresaPais, Maria Joãoinfo:eu-repo/semantics/openAccess2023-07-01T06:12:01Zoai:oai.revista.spmi.pt:article/2163Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T11:01:56.952749Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Anticoagulation in clinical practice -2nd Part: the use of heparins
Anticoagulação na prática clínica -2ªparte: utilização das heparinas
title Anticoagulation in clinical practice -2nd Part: the use of heparins
spellingShingle Anticoagulation in clinical practice -2nd Part: the use of heparins
Timóteo, Ana Teresa
heparina não fraccionada
heparinas de baixo peso molecular
trombo­ citopénia
actividade anti-Xa
unfractionated heparin
low-mo­lecular weight heparin
thrombocytopenia
anti­ Xa activity
title_short Anticoagulation in clinical practice -2nd Part: the use of heparins
title_full Anticoagulation in clinical practice -2nd Part: the use of heparins
title_fullStr Anticoagulation in clinical practice -2nd Part: the use of heparins
title_full_unstemmed Anticoagulation in clinical practice -2nd Part: the use of heparins
title_sort Anticoagulation in clinical practice -2nd Part: the use of heparins
author Timóteo, Ana Teresa
author_facet Timóteo, Ana Teresa
Pais, Maria João
author_role author
author2 Pais, Maria João
author2_role author
dc.contributor.author.fl_str_mv Timóteo, Ana Teresa
Pais, Maria João
dc.subject.por.fl_str_mv heparina não fraccionada
heparinas de baixo peso molecular
trombo­ citopénia
actividade anti-Xa
unfractionated heparin
low-mo­lecular weight heparin
thrombocytopenia
anti­ Xa activity
topic heparina não fraccionada
heparinas de baixo peso molecular
trombo­ citopénia
actividade anti-Xa
unfractionated heparin
low-mo­lecular weight heparin
thrombocytopenia
anti­ Xa activity
description The authors review, in this, the second part of the theme "anticoagulation in clinical prac­tice", the use of heparins in clinical practice. First, the use of unfractionated heparin, is discussed its indicated uses in inpatients, with often consequent long in-patient admission ti­mes, as well as the disadvantages of its use on the outpatient basis e.g. difficult use at home and complex monitorisation. Secondly, the authors' present low molecular weight hepa­rins, which combine easy administration with easy monitorisation, making their total cost lower than that of unfractionated heparin. Caution must be exercised in their implemen­tation, as each low molecular weight heparin has an individual profile that must be asses­sed in each clinical situation. To date, all studies point to a beneficial effect with the use of the various unfractionated heparins in their different clinical settings. lt seems probable that new indications will appear.
publishDate 1998
dc.date.none.fl_str_mv 1998-12-31
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://revista.spmi.pt/index.php/rpmi/article/view/2163
url https://revista.spmi.pt/index.php/rpmi/article/view/2163
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://revista.spmi.pt/index.php/rpmi/article/view/2163
https://revista.spmi.pt/index.php/rpmi/article/view/2163/1531
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Sociedade Portuguesa de Medicina Interna
publisher.none.fl_str_mv Sociedade Portuguesa de Medicina Interna
dc.source.none.fl_str_mv Internal Medicine; Vol. 5 No. 4 (1998): Outubro/ Dezembro; 264-270
Medicina Interna; Vol. 5 N.º 4 (1998): Outubro/ Dezembro; 264-270
2183-9980
0872-671X
reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833591502014513152